123 related articles for article (PubMed ID: 15280169)
1. Angiogenesis and pulmonary fibrosis: feast or famine?
Keane MP
Am J Respir Crit Care Med; 2004 Aug; 170(3):207-9. PubMed ID: 15280169
[No Abstract] [Full Text] [Related]
2. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
Cosgrove GP; Brown KK; Schiemann WP; Serls AE; Parr JE; Geraci MW; Schwarz MI; Cool CD; Worthen GS
Am J Respir Crit Care Med; 2004 Aug; 170(3):242-51. PubMed ID: 15117744
[TBL] [Abstract][Full Text] [Related]
3. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis.
Keane MP; Belperio JA; Burdick MD; Lynch JP; Fishbein MC; Strieter RM
Am J Respir Crit Care Med; 2001 Dec; 164(12):2239-42. PubMed ID: 11751193
[TBL] [Abstract][Full Text] [Related]
4. [Neovascularization in ocular tissues: mechanisms and role of proangiogenic and antiangiogenic factors].
Nowak JZ; Wiktorowska-Owczarek A
Klin Oczna; 2004; 106(1-2):90-7. PubMed ID: 15218775
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
[TBL] [Abstract][Full Text] [Related]
7. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
[TBL] [Abstract][Full Text] [Related]
8. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
9. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
Keane MP; Belperio JA; Arenberg DA; Burdick MD; Xu ZJ; Xue YY; Strieter RM
J Immunol; 1999 Nov; 163(10):5686-92. PubMed ID: 10553099
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?
Tzouvelekis A; Anevlavis S; Bouros D
Respir Res; 2006 May; 7(1):82. PubMed ID: 16725031
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokines in angiogenesis related to pulmonary fibrosis.
Strieter RM; Belperio JA; Keane MP
Chest; 2002 Dec; 122(6 Suppl):298S-301S. PubMed ID: 12475804
[TBL] [Abstract][Full Text] [Related]
13. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
14. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
Keane MP; Arenberg DA; Lynch JP; Whyte RI; Iannettoni MD; Burdick MD; Wilke CA; Morris SB; Glass MC; DiGiovine B; Kunkel SL; Strieter RM
J Immunol; 1997 Aug; 159(3):1437-43. PubMed ID: 9233641
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
[TBL] [Abstract][Full Text] [Related]
16. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
17. Neovascularization in idiopathic pulmonary fibrosis: too much or too little?
Renzoni EA
Am J Respir Crit Care Med; 2004 Jun; 169(11):1179-80. PubMed ID: 15161610
[No Abstract] [Full Text] [Related]
18. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors.
Viloria-Petit A; Miquerol L; Yu JL; Gertsenstein M; Sheehan C; May L; Henkin J; Lobe C; Nagy A; Kerbel RS; Rak J
EMBO J; 2003 Aug; 22(16):4091-102. PubMed ID: 12912908
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of angiogenic potential of endothelial cells by contact with retinal pigment epithelial cells in a model simulating pathological conditions.
Dardik R; Livnat T; Nisgav Y; Weinberger D
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6188-95. PubMed ID: 20702828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
